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Now is the time to prepare the next generation of
doctors to work in the artiﬁcial intelligence-enabled
health system, bringing their humanity to the
machine–patient interface.
Introduction
We are experiencing a rapid expansion of new tech-
nologies which are fusing the digital and biological
worlds. New digital technologies—such as artiﬁcial
intelligence, electronic health records and Big Data,
telemedicine, ‘wearables’ for home monitoring and
virtual/augmented realities—are shaping the future
of medicine to become more eﬃcient, more accur-
ate and more sustainable.1 Digital systems from
industry leaders such as DeepMind and IBM
Watson are already being tested for use in health-
care in the UK and the United States.
Faced by machines that outperform us in many
areas, some clinicians fear that artiﬁcial intelligence
will render them redundant. This is, however, to
underestimate the role and value of the doctor to
the patient and society. Yes, artiﬁcial intelligence
has the potential to precipitate one of the greatest
changes in the role of the doctor to date, but this is
not something to be feared. Change is inevitable, but
we believe the core values that characterise a good
doctor will remain unchanged.
In contemporary culture, there is a timeless hero
known simply as ‘The Doctor’ who regularly regen-
erates to meet the demands of a new generation of
humans. Despite the anticipation – and even anxiety
– of each regeneration, we quickly get used to each
new incarnation of ‘The Doctor’ because the core
principles hold ﬁrm.2
So, too, in the age of artiﬁcial intelligence. Doctors
will need to adapt: to let go of old roles, and to ﬁnd
where they can be most relevant, and make most
impact. In most reviews of artiﬁcial intelligence, it is
the computer algorithm that takes centre stage: what
can it do better than humans. In this article, we have
put the spotlight back on the human doctor: their
role and their unique gift – to be human, when a
perfect algorithm is not enough.
The doctor as the human—artificial
intelligence interface in diagnosis
Clinical diagnosis relies on a doctor’s interpretation
of signs, symptoms, physical examination and rele-
vant investigations. It is vulnerable to a doctor’s fal-
lible memory, incomplete knowledge and cognitive
bias.3,4 Artiﬁcial intelligence can potentially provide
highly accurate data on probable diagnosis, investi-
gation pathway and recommended treatment, based
on objective evaluation of all data and medical evi-
dence available at that point in time: comprehensive
and up-to-the-minute.
Artiﬁcial intelligence will require accurate data
input in order to generate a correct diagnosis.
Human experiences of symptoms do not always trans-
late perfectly into medical terminology, and ‘taking a
good history’ will remain a key skill in clinical diagno-
sis. This is also the time that trust is earned. A doctor
who listens well and shows empathy ismore likely to be
given the ‘hidden data’. Sometimes this is direct – ‘I’ve
not wanted to tell anybody but . . .’ or via an invitation
to ask more – ‘I didn’t come last week because things
have been diﬃcult . . .’. A human doctor knows that a
wrong move at this point can close down any future
engagement, whereas the right cue may enable the
patient to seek and receive the help they need.
There is also the issue of our human tendency to
report inaccurate or irrelevant information,
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including embellishment, exaggerations or even lies.
This is more readily recognised by other humans
than machines. The physician will have an important
role as the interface between the ‘human’ perception
of illness and the ‘accurate’ data input into the
machine.
The fundamental question though may not be
‘Can this machine understand me?’, but ‘Do I want
this machine to understand me?’ At some point, arti-
ﬁcial intelligence will almost certainly be able to simu-
late empathic listening and evaluate the veracity of
what it is being told. Chatbots are on the rise, and
artiﬁcial intelligence interpretation of body language
is progressing. But do I, as a patient, want to share
this information with a machine? And do I want that
machine to be the ﬁrst ‘person’ to tell me about my
cancer, however ‘emotionally appropriate’ their simu-
lated responses may be?
Eﬀective communication of a serious diagnosis
requires considerate assessment of a patient’s hopes,
fears and expectations. Much of this is non-verbal. A
skilful physician ‘reads between the lines’. These
channels of communication are instinctual and they
inﬂuence the doctor’s consulting behaviour on a
minute-by-minute basis, often without them realising.
The most sophisticated dimensions of this human-to-
human interaction happen at an innate level and
cannot be replicated by an algorithm.
Sometimes artiﬁcial intelligence algorithms may
simply fail due to a lack of appropriate data. For
example, in rare diseases, there may be insuﬃcient
‘training’ data to support artiﬁcial intelligence. A
vital new skill for the doctor in this era will be to
know the limits of artiﬁcial intelligence and how to
make diagnostic decisions in these situations.
Similarly in cases of multi-morbidity, treatment
decisions become more complex, and potentially
more nuanced as some decisions may improve one
disease at the expense of another, and again
the data may be less certain. It is likely that
this will be a particular area where human value
judgements are helpful. Another challenge will be in
cases of diagnostic equivalence, i.e. where multiple
artiﬁcial intelligence-derived diagnoses or solutions
are proposed which may be of equal likelihood.
The physician will need to manage this uncertainty
and communicate with the patient.
Triaging the doctor to the high-risk patient
The current health system depends on triage done by
humans, sometimes according to protocol, sometimes
according to knowledge and experience. Such proto-
cols are based on few variables are therefore fairly
blunt tools.
Triage by artiﬁcial intelligence could be faster,
more accurate and more sensitive, based on many
more variables than are currently possible. Input
variables would include both symptoms elicited by
phone and live tracking of clinical measurements eli-
cited by wearable or implantable technology. Triage
need no longer be simplistically divided into broad
categories (such as red, amber and green) but can
be adjusted on a continuous scale of risk and need
for rapid intervention. The continuous datastream
could provide early triggers to the emergency ser-
vices, such that your ambulance – driverless but
with human paramedic – may be pulling up at your
door almost before you know you need it.
The role of the doctor in the emergency room is
likely to be as team-leader, knowledge-handler and
communicator. The coordination of the rapidly evol-
ving estimates of diagnostic certainty, recommended
treatment pathways, and, where possible, discus-
sion of potential beneﬁt and risk with patient and
relatives is going to be key. These roles do not need
to be restricted to a doctor, but they do require a
human.
Directing the doctor to the complex, the
nuanced and the ‘doesn’t fit’
Many milder ailments may be handled almost
entirely by artiﬁcial intelligence-informed virtual
health interfaces. In cases where there is diagnostic
certainty and well-established, eﬀective and safe
treatments, it may not be necessary to have a
human interface at all or it could be provided as an
option, similar to many telephone banking systems or
electronic help desks.
If most routine low-risk ailments are being dealt
with by artiﬁcial intelligence, it is anticipated that
there would be more time for clinicians to focus on
those patients who speciﬁcally need an experienced
human clinician. These might be patients with more
complex conditions (rare disease or multi-morbidity)
or where the diagnostic certainty is low.
Alternatively, it may be the patient’s needs, rather
than their condition, that is complex. Healthcare
decisions for a patient with learning diﬃculties,
dementia, addiction or signiﬁcant social deprivation
are likely to require more human support than for
other patients.
The doctor as patient educator and advisor
Traditionally, the doctor has been gatekeeper for
medical knowledge and making medical decisions
for the patient. In the artiﬁcial intelligence era, the
medical knowledge which forms the basis of decision-
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making will be as accessible to the patient as to the
doctor. Humans are, however, notoriously poor at
comprehending probability and evaluating risk, and
especially so when it pertains to their own health or
the health of a loved one. Therefore, for most
patients, one of the most important roles for the
doctor will be to understand risk and communicate
this to the patient, whether around diagnostic cer-
tainty, the safety of an intervention or the eﬃcacy
of a treatment. The doctor will also need to be able
to explain the way artiﬁcial intelligence has ‘formu-
lated’ a treatment plan. It is worth noting that this
does not require a detailed knowledge of machine
learning techniques. Just as doctors use other inves-
tigations such as a magnetic resonance imaging scan
without a detailed knowledge of its mechanics, so it
should be possible to communicate the value of arti-
ﬁcial intelligence in informing clinical decisions with-
out deep computational knowledge.
The doctor as patient advocate
The doctor has a unique experience of the front line
of healthcare, being privileged to listen to patients
on a daily basis, often caring for the same individ-
uals over many years, and possessing a critical
appreciation of both the possibilities and limitations
of medicine. From this vantage point, they are well
placed to listen and respond to the needs and prio-
rities of individual patients and the collective patient
group. This advocacy role is particularly important
where there are competing interests – for example,
limited resources to be allocated between patients or
patient groups. Such issues may be complex, and
emotionally charged, but are at least reasonably
transparent. Not everybody may agree with the
ﬁnal decision, but the process leading to that deci-
sion is open to scrutiny.
In the artiﬁcial intelligence era, there is a risk that
stakeholders can inﬂuence patient care through
embedding ‘hidden’ values within the algorithms.
As Paul Hodgkin notes, ‘But what happens when dif-
ferent values conﬂict? A drug ﬁrm funding a machine
learning system might want to increase sales, whereas
a healthcare system might want to hold down costs
and patients might prioritise safety’.5 All of us –
whether patients, public or doctors – will need to
engage with this process and to hold the ‘rules’ of
the algorithm to account. We need to move from a
‘black-box’ to a ‘glass-box’ mentality. In this debate,
the key contribution of the doctor will be their under-
standing of the two overlapping domains – the
experience of patients in the ‘real world’ and their
specialist knowledge of both the potential and risks
of medicine.
The doctor at the end of life
In his ‘zeroth’ law of robotics, Issac Asimov proposed
that the most basic tenet of artiﬁcial intelligence was
to ‘not injure a human or through inaction allow a
human being to come to harm’.6 This principle works
in most situations, but may fail spectacularly when it
comes to end-of-life decisions. In contrast, a human
physician recognises that some human decisions are
not simply a matter of survival-based logic. Despite
the similarity of Asimov’s law to Hippocratic con-
cepts, humans have a more nuanced understanding
of beneﬁcence and non-maleﬁcence which incorpor-
ates not just length of life but also quality of life. The
limitations of artiﬁcial intelligence in this area cannot
be overcome by simply inserting a quality-adjusted-
life-year threshold at which life is no longer deemed
worth preserving. One patient with a terminal disease
may choose palliation; another will opt for further
chemotherapy. The patient may make this decision
based on many variables that would also be available
to the artiﬁcial intelligence algorithm, and yet, the
ﬁnal decision needs to be the patient’s alone. Such
decisions must always remain outside an algorithm.
Conclusions
The advent of artiﬁcial intelligence will be a seismic
shift in healthcare, and the doctor’s role will need to
evolve. In this article, we have considered just some
of these aspects, highlighting areas of particular
opportunity or challenge. Being a good physician in
the era of artiﬁcial intelligence will require a refocuss-
ing of our skillset and an even bigger shift in mindset.
The rate of progress in artiﬁcial intelligence is such
that medical schools and postgraduate training
schemes need to be engaging with this revolution
now. We need to ensure that our new doctors
are equipped to handle the artiﬁcial intelligence-
deconstructed world that they will be living in.
In this new world, artiﬁcial intelligence will
seamlessly transcribe every patient and every clinical
presentation into input data from which it will
generate output probabilities of disease, treatment
eﬃcacy, adverse events and death. In most cases, it
will do this faster, more reliably and cheaper than a
human. Some will see this as a threat; others as an
opportunity.
This article is not about artiﬁcial intelligence – it is
about the new doctor and how they ﬁnd their place in
the artiﬁcial intelligence-enabled health system. The
need will be for the human–artiﬁcial intelligence
interface, the knowledge-handler, the empathic com-
municator. We believe that now is the time to start
preparing this next generation of doctors to work
alongside artiﬁcial intelligence, knowing both its
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value and its limitations – and, in so doing, to dis-
cover their own irreplaceable value to patients and
society.
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